Nicholas Lorusso
Stock Analyst at TD Cowen
(3.53)
# 2,465
Out of 4,491 analysts
13
Total ratings
66.7%
Success rate
28.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nicholas Lorusso
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMTX Immatics | Maintained: Buy | n/a | $9.91 | - | 4 | Jun 17, 2026 | |
| KROS Keros Therapeutics | Maintained: Hold | n/a | $11.38 | - | 2 | May 14, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $960 | $664.59 | +44.45% | 1 | May 6, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintained: Buy | $60 → $65 | $64.39 | +0.95% | 6 | Apr 28, 2026 |
Immatics
Jun 17, 2026
Maintained: Buy
Price Target: n/a
Current: $9.91
Upside: -
Keros Therapeutics
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $11.38
Upside: -
Regeneron Pharmaceuticals
May 6, 2026
Maintained: Buy
Price Target: $960
Current: $664.59
Upside: +44.45%
Kiniksa Pharmaceuticals International,
Apr 28, 2026
Maintained: Buy
Price Target: $60 → $65
Current: $64.39
Upside: +0.95%